Wertpapierdatensatz · archiviertes Quartal
ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare · Biotechnology
17Erfasste Halter
0Δ Inhaber
41.95MGehaltene Aktien
$9.87BGemeldeter Wert
+0Neue Positionen
−0Ausstiege
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -1.7% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | +3 | 107.61M | $32.37B | +7 | −3 |
| Q1 2026 | 161 | -2 | 108.78M | $35.89B | +4 | −7 |
| Q4 2025 | 162 | -2 | 118.83M | $47.26B | +1 | −2 |
| Q3 2025 | 24 | +1 | 85.59M | $39.02B | +2 | −2 |
| Q2 2025 | 21 | -1 | 76.99M | $25.10B | — | −1 |
| Q1 2025 | 19 | +2 | 40.24M | $10.86B | +3 | −1 |
| Q4 2024 | 17 | 0 | 41.95M | $9.87B | — | — |
| Q3 2024 | 16 | +1 | 39.28M | $10.80B | +2 | −1 |
| Q2 2024 | 15 | — | 40.30M | $9.79B | — | — |
Wer es hält · Q4 2024
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 16.60M | +0.6% | $3.91B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.20M | -15.3% | $987.51M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.20M | -15.3% | $987.51M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.20M | -15.3% | $987.51M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.20M | -15.3% | $987.51M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.20M | -15.3% | $987.51M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.20M | -15.3% | $987.51M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.20M | -15.3% | $987.51M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.20M | -15.3% | $987.51M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 10 | Baillie Gifford ✦ | 4.04M | -17.3% | $950.71M | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 11 | Baillie Gifford ✦ | 4.04M | -17.3% | $950.71M | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 12 | Baillie Gifford ✦ | 4.04M | -17.3% | $950.71M | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 4.04M | -17.3% | $950.71M | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 14 | Dodge & Cox ✦ | 3.54M | -2.3% | $833.06M | 0.5% | ▼ Trim | 3 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (passiv) | 3.42M | — | $805.46M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 3.32M | -3.8% | $781.09M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 3.32M | -3.8% | $781.09M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 18 | Norges Bank ✦ (passiv) | 2.46M | +3.4% | $577.94M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passiv) | 2.21M | +2.8% | $518.37M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passiv) | 2.21M | +2.8% | $518.37M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 813.36K | +60.9% | $191.39M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 813.36K | +60.9% | $191.39M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 813.36K | +60.9% | $191.39M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 813.36K | +60.9% | $191.39M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 813.36K | +60.9% | $191.39M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 813.36K | +60.9% | $191.39M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 27 | Marshall Wace ✦ | 378.65K | +496.6% | $89.10M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 28 | Marshall Wace ✦ | 378.65K | +496.6% | $89.10M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 29 | Marshall Wace ✦ | 378.65K | +496.6% | $89.10M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 363.08K | +9.3% | $85.44M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 363.08K | +9.3% | $85.44M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 32 | Millennium Management ✦ | 333.44K | +32.9% | $78.46M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 33 | Two Sigma Investments ✦ | 107.12K | +459.4% | $25.21M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 34 | Adage Capital Partners ✦ | 93.06K | -19.8% | $21.90M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 35 | Citadel Advisors ✦ | 65.39K | +173.2% | $15.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 36 | Citadel Advisors ✦ | 65.39K | +173.2% | $15.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 37 | Gotham Asset Management ✦ | 10.92K | -37.8% | $2.57M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 38 | Bridgewater Associates ✦ | 6.45K | +222.3% | $1.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 4.30K Anteile, $1,422 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q4 2024 ·
Methodik ·
Über die API abrufen